Abstract

Pathogenic variants of the aconitase 2 gene (ACO2) are responsible for a broad clinical spectrum involving optic nerve degeneration, ranging from isolated optic neuropathy with recessive or dominant inheritance, to complex neurodegenerative syndromes with recessive transmission. We created the first public locus-specific database (LSDB) dedicated to ACO2 within the “Global Variome shared LOVD” using exclusively the Human Phenotype Ontology (HPO), a standard vocabulary for describing phenotypic abnormalities. All the variants and clinical cases listed in the literature were incorporated into the database, from which we produced a dataset. We followed a rational and comprehensive approach based on the HPO thesaurus, demonstrating that ACO2 patients should not be classified separately between isolated and syndromic cases. Our data highlight that certain syndromic patients do not have optic neuropathy and provide support for the classification of the recurrent pathogenic variants c.220C>G and c.336C>G as likely pathogenic. Overall, our data records demonstrate that the clinical spectrum of ACO2 should be considered as a continuum of symptoms and refines the classification of some common variants.

Measurement(s)

sequence_variant • Phenotypic variability

Technology Type(s)

DNA sequencing • Ophthalmologist

Factor Type(s)

sequence variant • phenotype

Sample Characteristic - Organism

Homo sapiens

Machine-accessible metadata file describing the reported data: https://doi.org/10.6084/m9.figshare.13574528

Details

Title
ACO2 clinicobiological dataset with extensive phenotype ontology annotation
Author
Guehlouz Khadidja 1 ; Foulonneau, Thomas 2 ; Amati-Bonneau Patrizia 3 ; Charif Majida 4 ; Colin, Estelle 3 ; Bris Céline 3 ; Desquiret-Dumas Valérie 3 ; Milea, Dan 5 ; Gohier, Philippe 1 ; Procaccio Vincent 3 ; Bonneau, Dominique 3 ; den Dunnen Johan T 6   VIAFID ORCID Logo  ; Lenaers Guy 2   VIAFID ORCID Logo  ; Reynier Pascal 3   VIAFID ORCID Logo  ; Ferré, Marc 2   VIAFID ORCID Logo 

 Centre Hospitalier Universitaire d’Angers, Département d’Ophtalmologie, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283) 
 Université d’Angers, Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Angers, France (GRID:grid.7252.2) (ISNI:0000 0001 2248 3363) 
 Université d’Angers, Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Angers, France (GRID:grid.7252.2) (ISNI:0000 0001 2248 3363); Centre Hospitalier Universitaire d’Angers, Département de Biochimie et Génétique, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283) 
 Université d’Angers, Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Angers, France (GRID:grid.7252.2) (ISNI:0000 0001 2248 3363); Mohammed First University, Genetics, and immuno-cell therapy Team, Oujda, Morocco (GRID:grid.7252.2) 
 Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670) 
 Leiden University Medical Centre, Human Genetics and Clinical Genetics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20524463
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2558265579
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.